Inex Onco TCS in more Phase II trials

Inex (TSE:IEX) and partner Elan (ELN) are starting 2 Phase II studies of Onco TCS in combination with etoposide in a total of 35 patients with relapsed aggressive non-Hodgkin's lymphoma (NHL). The tri...